Loading...
Researchers develop a groundbreaking silk peptide nanoparticle system for co-delivering erlotinib and curcumin, marking a significant advancement in targeted cancer therapy with the potential to overcome current treatment limitations.
1003 Bishop St, Suite 1700 Honolulu, HI 96813, United States
You received this email because you signed up on our website.
© 2024
